ASX - By Stock
|
ZLD |
Re:
Ann: ZLD Advances HOPE Autism Drug Program with U.S FDA Meeting
|
|
RonaldMcdonald
|
2 |
1.2K |
3 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
2
|
1.2K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures US$1.4M unsecured Chairman loan facility
|
|
RonaldMcdonald
|
20 |
6.9K |
3 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
20
|
6.9K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures US$1.4M unsecured Chairman loan facility
|
|
RonaldMcdonald
|
20 |
6.9K |
5 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
20
|
6.9K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures US$1.4M unsecured Chairman loan facility
|
|
RonaldMcdonald
|
20 |
6.9K |
1 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
20
|
6.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures US$1.4M unsecured Chairman loan facility
|
|
RonaldMcdonald
|
20 |
6.9K |
1 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
20
|
6.9K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Summary
|
|
RonaldMcdonald
|
47 |
26K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
47
|
26K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
RonaldMcdonald
|
217 |
74K |
9 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
217
|
74K
|
9
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zeliras diabetic nerve pain drug outperforms Lyrica
|
|
RonaldMcdonald
|
217 |
74K |
11 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
217
|
74K
|
11
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
RonaldMcdonald
|
20 |
6.1K |
3 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
20
|
6.1K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD secures US$8.6 million funding for HOPE 1 US FDA trials
|
|
RonaldMcdonald
|
22 |
5.7K |
2 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
22
|
5.7K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
RonaldMcdonald
|
12 |
4.0K |
6 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
12
|
4.0K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLD Completes Enrolment for Diabetic Nerve Pain Drug Trial
|
|
RonaldMcdonald
|
24 |
11K |
5 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
24
|
11K
|
5
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled
|
|
RonaldMcdonald
|
12 |
3.4K |
4 |
16/09/22 |
16/09/22 |
ASX - By Stock
|
12
|
3.4K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Investor Briefing Webinar Details
|
|
RonaldMcdonald
|
6 |
1.9K |
4 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
6
|
1.9K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
0 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
395
|
163K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
4 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
395
|
163K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Pause in Trading
|
|
RonaldMcdonald
|
16 |
7.0K |
4 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
16
|
7.0K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
2 |
12/07/22 |
12/07/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
RonaldMcdonald
|
99 |
39K |
3 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
99
|
39K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
RonaldMcdonald
|
99 |
39K |
0 |
07/07/22 |
07/07/22 |
ASX - By Stock
|
99
|
39K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Termination of Scheme Implementation Deed with HHI
|
|
RonaldMcdonald
|
50 |
18K |
1 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
50
|
18K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Termination of Scheme Implementation Deed with HHI
|
|
RonaldMcdonald
|
50 |
18K |
2 |
23/06/22 |
23/06/22 |
ASX - By Stock
|
50
|
18K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Termination of Scheme Implementation Deed with HHI
|
|
RonaldMcdonald
|
50 |
18K |
2 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
50
|
18K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Termination of Scheme Implementation Deed with HHI
|
|
RonaldMcdonald
|
50 |
18K |
3 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
50
|
18K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
RonaldMcdonald
|
99 |
39K |
0 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
99
|
39K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
RonaldMcdonald
|
99 |
39K |
1 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
99
|
39K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Hope 1 Longitudinal, Real-World Data Trial in ASD Results
|
|
RonaldMcdonald
|
99 |
39K |
0 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
99
|
39K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
1 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
395
|
163K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
2 |
11/05/22 |
11/05/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Update - Consolidation/Split - ZLD
|
|
RonaldMcdonald
|
43 |
24K |
3 |
07/05/22 |
07/05/22 |
ASX - By Stock
|
43
|
24K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira and Health House execute Scheme Implementation Deed
|
|
RonaldMcdonald
|
8 |
4.6K |
3 |
05/05/22 |
05/05/22 |
ASX - By Stock
|
8
|
4.6K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
2 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
8 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
395
|
163K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
youtube
|
|
RonaldMcdonald
|
11 |
5.2K |
2 |
25/04/22 |
25/04/22 |
ASX - By Stock
|
11
|
5.2K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
8 |
22/04/22 |
22/04/22 |
ASX - By Stock
|
395
|
163K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
2 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
2 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
395
|
163K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
1 |
12/04/22 |
12/04/22 |
ASX - By Stock
|
395
|
163K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Consolidation/Split - ZLD
|
|
RonaldMcdonald
|
21 |
14K |
4 |
18/03/22 |
18/03/22 |
ASX - By Stock
|
21
|
14K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
RonaldMcdonald
|
12 |
5.7K |
8 |
12/03/22 |
12/03/22 |
ASX - By Stock
|
12
|
5.7K
|
8
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
RonaldMcdonald
|
12 |
5.7K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
12
|
5.7K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
RonaldMcdonald
|
48 |
17K |
6 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
48
|
17K
|
6
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
RonaldMcdonald
|
395 |
163K |
11 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
395
|
163K
|
11
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
RonaldMcdonald
|
48 |
17K |
2 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
48
|
17K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira to acquire Health House International Limited
|
|
RonaldMcdonald
|
48 |
17K |
2 |
26/02/22 |
26/02/22 |
ASX - By Stock
|
48
|
17K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: 2021 Annual General Meeting Presentation
|
|
RonaldMcdonald
|
8 |
2.8K |
4 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
8
|
2.8K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira receives $1.2 million cash R&D Tax Incentive
|
|
RonaldMcdonald
|
17 |
4.8K |
1 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
17
|
4.8K
|
1
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Partial Receipt Of Zeliras EDCDM Technology License Fee
|
|
RonaldMcdonald
|
23 |
7.1K |
4 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
23
|
7.1K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
RonaldMcdonald
|
63 |
20K |
9 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
63
|
20K
|
9
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelira expands into NZ via exclusive distribution agreement
|
|
RonaldMcdonald
|
63 |
20K |
9 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
63
|
20K
|
9
|
|